This medical pathophysiology diagram illustrates the indirect central nervous system (CNS) damage mechanisms associated with SARS-CoV-2 infection, specifically focusing on maternal-fetal immune interactions and fetal neurodevelopment. The flowchart begins with the virus triggering a reduction in T cell numbers and a loss of maternal-fetal tolerance. It details the activation of T helper (CD4+) subsets (Th1, Th2), T cytotoxic (CD8+) cells, neutrophils (releasing IL-8), monocytes, macrophages, and the complement system. These immune responses converge on a central 'Inflammatory environment / Cytokine storm.' Within the fetal CNS, this environment triggers microglial activation (releasing glutamate and quinolinic acid) and astrocyte activation (releasing free radicals and cytokines like IL-6, TNF̑, and IL-1̒). These mediators lead to direct injury of oligodendrocytes (maturation arrest, death) and neurons (axonal loss, impaired migration). Simultaneously, HPA axis dysfunction and endocrine dysregulation (low progesterone, high glucocorticoids) lead to fetal programming and epigenetic changes. The culmination of these pathways results in abnormal cortical development, impaired synaptic pruning, and long-term psychiatric, cognitive, and behavioral impairments.

A pathophysiology diagram illustrating the relationship between infectious agents and neurodegenerative diseases within the central nervous system. The illustration depicts a sagittal view of the human brain with three highlighted regions corresponding to Alzheimer's Disease (orange), Parkinson's Disease (blue), and Amyotrophic Lateral Sclerosis (ALS, green). The flowchart begins with 'Viral or Bacterial Infection' entering the CNS, triggering 'Astrocyte and Microglia activation.' This lead to 'Inflammatory cytokine release' and ultimately 'Neuronal Death.' Detailed call-out boxes list molecular hallmarks for each condition: Alzheimer's shows increased Aβ plaques, Tau tangles, and TNF-α/IL-1β; Parkinson's shows increased α-synuclein Lewy bodies and various cytokines (TNF-α, RANTES, IFN); ALS shows increased TDP-43 aggregates, apoptosis, and excitotoxicity. The diagram emphasizes the role of neuroinflammation and glial cell immune responses in the progression of proteinopathies and neuronal loss across different neurological disorders.

A pathophysiology diagram illustrating the brain renin-angiotensin system (RAS) and its dual pathways leading to neurodegeneration or neuroprotection. The flowchart starts with brain angiotensinogen, converted to Angiotensin I (Ang I) by renin, and subsequently to Angiotensin II (Ang II) by Angiotensin-Converting Enzyme (ACE). The diagram depicts two opposing arms of the RAS axis. The 'harmful' arm involves Ang II binding to the AT1 Receptor (AT1R), which triggers vasoconstriction, oxidative stress, inflammation, and apoptosis, ultimately leading to neurodegeneration. Conversely, the 'protective' arm involves the conversion of Ang II to Ang 1-7 by ACE2, which acts on the MAS Receptor (MASR). This, along with Ang II signaling through the AT2 Receptor (AT2R), promotes vasodilation, anti-oxidation, and anti-inflammatory effects, resulting in neuroprotection. The balance between these outcomes is visually represented by a scale labeled 'RAS Axis' at the bottom. Anatomical illustrations of neurons and neurovascular structures are included to provide central nervous system context.

This pathophysiology diagram illustrates the process of 'astrosenescence' and its contribution to neurodegenerative disease within the central nervous system (CNS). The flowchart begins with a healthy, star-shaped astrocyte encountering 'Senescence Induction' triggers, including telomere erosion, oxidative stress, proteasome inhibition, beta-amyloid, and pro-inflammatory signaling. Post-induction, the astrocyte transforms into a larger, pentagonal senescent cell. This senescent astrocyte establishes a 'Pro-inflammatory Microenvironment' by secreting factors (depicted as purple hexagons) characteristic of a Senescence-Associated Secretory Phenotype (SASP). The diagram highlights three primary downstream effects: 1) 'Neuronal Dysfunction and Death,' represented by a neuron with a red strike-through; 2) 'Paracrine Senescence,' where secreted factors induce senescence in neighboring healthy astrocytes; and 3) general 'Tissue Dysfunction' involving altered cellular morphology. The terminal outcome of these integrated pathways is categorized as 'Neurodegenerative Disease.' This visual serves as an educational summary of how cellular aging in glia disrupts homeostasis and promotes chronic pathology in the brain.

This medical infographic and pathophysiology flowchart compare Ischemic and Hemorrhagic stroke mechanisms. At the top, two axial brain illustrations highlight affected regions: a blue-shaded area in the left hemisphere represents ischemia, while a red-shaded area in the right hemisphere represents hemorrhage. Listed etiologies for Ischemic Stroke include small artery occlusion, large artery atherosclerosis, and cardio-aortic embolism. Hemorrhagic causes include antithrombolytic therapy, aneurysm, hypertension, arteriovenous malformation, and trauma. Below the illustrations, a logic flow depicts both conditions leading to cerebral hypo-perfusion. The ischemic pathway outlines oxygen/glucose deprivation, ionic pump failure, and lactic acidosis. The hemorrhagic pathway highlights red blood cell (RBC) lysis and ATP depletion. Both pathways converge on common secondary brain injury mechanisms: neuroinflammation, excitotoxicity, oxidative damage, and cerebral edema, all of which terminate in neuronal necrosis. This diagram serves as an educational tool for neurology students to understand the diverging initiating events and converging molecular outcomes of different stroke types.

Educational flowchart and clinical imaging panel depicting the study design for a randomized controlled trial (LASER trial) on edoxaban initiation timing following atrial fibrillation-related ischemic stroke. The flowchart illustrates the timeline from screening and baseline assessment to randomization into two arms: early edoxaban initiation (Day 0–5, n=100) and late initiation (Day 6–14, n=50). Integrated into the flowchart are axial non-contrast CT scans of the head. Baseline assessment images demonstrate various stroke manifestations, including acute ischemic infarcts appearing as focal hypodensities and parenchymal hematomas (PH1 and PH2) characterized by hyperdense focal lesions with surrounding edema. Follow-up CT scan panels at 7 ± 2 days post-initiation monitor for outcomes such as asymptomatic or symptomatic hemorrhagic transformation (HT), recurrent ischemic events, and encephalomalacia. The diagram uses color-coded boxes to delineate study phases and clinical endpoints, highlighting the trial's focus on balancing the prevention of recurrent ischemia against the risk of hemorrhagic transformation in stroke management.

This infographic and diagnostic imaging panel illustrate machine learning applications in neuroradiology, specifically for stroke management. On the left, a flowchart describes a four-stage clinical cycle: 1) Initial Assessment (risk prediction and biomarkers), 2) Diagnosis and Decision Making (stroke type differentiation and vascular mapping), 3) Treatment Planning (therapeutic strategy and procedure assistance), and 4) Post-treatment Monitoring (outcome prediction and follow-up). The right panel provides diagnostic comparisons. The top section (A and B) displays an axial head CT showing a subtle left subdural hemorrhage, with Image B utilizing AI-based software to highlight the hemorrhagic area in red on a color-coded map. The bottom section compares three axial brain scans: a non-enhanced CT (left), an AI-augmented CT with red overlays highlighting an ischemic stroke (middle), and a corresponding Diffusion-Weighted Imaging (DWI) MRI (right) that confirms the ischemic area through restricted diffusion signal. The content serves as an educational overview of how artificial intelligence assists in detecting infarcts and hemorrhages while streamlining neuro-radiological workflows.

This clinical photograph displays a patient's torso positioned for a preoperative localization procedure, specifically for identifying a surface puncture point prior to video-assisted thoracoscopic surgery (VATS). The image shows the upper chest and right axillary region. Key visual features include blue ink markings on the skin: three '+' signs serve as fiduciary marks representing alignment lines from a CT gantry for anatomical orientation, and one '*' asterisk marks the specific identified puncture site. Red laser alignment lines are projected vertically and horizontally across the patient's skin, originating from a radiotherapy simulator used for 3D simulation and localization. These markings are essential for guiding the injection of methylene blue dye to stain the pathway to a pulmonary lesion. The educational focus is on the clinical workflow of image-guided preoperative marking in thoracic surgery, demonstrating the integration of diagnostic imaging (CT) with physical simulation for accurate lesion localization.

This is a high-resolution clinical photograph of a periorbital eyelid lesion consistent with xanthelasma palpebrarum. Modality and technique: Clinical photography, color RGB, close-up macro of the left upper eyelid and medial canthus with frontal/oblique view to document lesion position and morphology. Anatomical localization: Periorbital skin around the left palpebral region; upper eyelid; medial canthus; integumentary system. Visual features: Soft, well-circumscribed, yellow to pale-orange plaque on the superior medial eyelid, with smooth surface and slight flattening at the margins. Coloration more pronounced toward the medial aspect; surrounding skin shows mild hyperpigmentation and normal folds. Pathologic inference: Xanthelasma represents lipid-laden macrophage infiltration in the dermis; visually appears as lipid-rich, cholesterol-laden deposits beneath the epidermis; while biopsy would show foamy histiocytes and cholesterol clefts. Diagnostic significance: Strong clinical cue for dyslipidemia; often associated with hyperlipidemia or inherited lipid disorders; warrants lipid profile evaluation and cardiovascular risk assessment. Clinical use: Educational for dermatology and ophthalmology trainees; differential includes syringomas, milia, sebaceous hyperplasia; radiology not applicable; management involves lipid control, laser or surgical removal for cosmetic reasons. Useful in teaching exam-style questions about diagnosis, morphology, differential, and systemic associations. This image anchors discussion of dermatologic signs correlating with systemic lipid disorders.

This is a high-resolution clinical photography image capturing a solitary nodular lesion on the cutaneous surface of the upper limb. Modality: Clinical photography with macro close-up; technique: standard color imaging without magnification accessories; acquisition: single still frame. Anatomical localization: integumentary system, skin of the arm (upper extremity), dermal/epidermal layers; laterality not specified. Visual features: a small, dome-shaped, pink-red papule with slight translucency and a smooth, shiny surface. The lesion measures roughly 5 mm in diameter and shows a well-defined margin with subtle pearly quality. Fine telangiectatic vessels may be present on the surface; no gross ulceration is evident. Surrounding skin demonstrates mild actinic change and background sun exposure changes. Impression: lesion consistent with nodular basal cell carcinoma spectrum, characterized by dermal nests of basaloid cells in histology, aligned palisading at the tumor-stroma interface (in presumed biopsy specimens). Clinical significance: nodular BCC is the most common skin cancer variant; often locally invasive but rarely metastasizes; early recognition supports elective excision with clear margins and Mohs micrographic surgery when indicated. Differential considerations include keratoacanthoma, sebaceous hyperplasia, squamous cell carcinoma, and benign adnexal tumors. This image is suitable for educational demonstrations of cutaneous oncology, dermatology training, and image-guided diagnosis discussions; it supports correlation with histopathology and treatment planning.

This diagnostic image contains a single-lead electrocardiogram (ECG) rhythm strip from lead II, paired with a corresponding ladder diagram to illustrate cardiac conduction. The ECG demonstrates group beating with variable R-R intervals (900ms and 1120ms), absence of normal sinus P waves, and the presence of retrograde P waves (inverted deflections following the QRS complexes). The visual evidence points to a junctional rhythm with retrograde atrial conduction and occasional reciprocal (echo) beats. The ladder diagram below the tracing provides a schematic representation of conduction across three levels: Atria (A), Atrioventricular node (AV), and Ventricles (V). It specifically denotes timing intervals (673ms, 900ms, 1120ms) and uses standard symbols to indicate points of origin (dots), antegrade and retrograde conduction pathways (angled lines), and conduction block (perpendicular bars). This material is designed for intermediate to advanced cardiovascular education, specifically focusing on complex arrhythmia interpretation and the electrophysiological mechanism of re-entrant junctional rhythms.

This diagnostic image displays multiple electrocardiogram (ECG) rhythm strips comparing control conditions (ECG CT) with a chronic diabetes mellitus model (ECG cDM-model). Panel (a) provides a reference anatomical diagram of ECG intervals, including the PQ, RR, PP, and QT intervals. Panels (b-d) show normal sinus rhythms from control subjects, characterized by regular P waves, standard QRS complexes, and consistent intervals. Panels (e-m) illustrate various pathological arrhythmias and morphological abnormalities associated with the cDM model. Key findings include: ST-segment elevation (e, g, h, i) suggesting myocardial injury or ischemia; QRS complex depression or inversion (j, k); supraventricular abnormalities such as an inverted P-wave (l) and a notched P-wave (indicated by a red arrow in g); and a second-degree atrioventricular (AV) block (m) characterized by non-conducted P waves and a slow, irregular rhythm. The recordings highlight the clinical significance of diabetic cardiomyopathy and its impact on cardiac electrical conduction and ventricular repolarization.

This diagnostic image displays a two-lead electrocardiogram (ECG) rhythm strip, likely from a Holter monitor, showing a regular sinus rhythm. The top tracing (Lead I) and bottom tracing (Lead II) demonstrate consistent PQRST morphology across a standard grid background. Each cardiac cycle consists of a visible P wave preceding a narrow QRS complex, followed by a symmetric T wave. The R-R intervals are regular, indicating a stable heart rate and rhythm. Clinically, this image serves as an educational example of normalized electrical conduction after recovery from high-grade atrioventricular block, specifically in the context of Lyme carditis treatment. The lack of PR prolongation or dropped beats highlights the resolution of the conduction delay. Key educational features include the 1:1 atrioventricular relationship and the absence of morphological abnormalities in the repolarization phase (T waves), confirming clinical stability upon discharge.

This procedural clinical photograph demonstrates the concurrent placement of a standard 12-lead electrocardiogram (ECG) and a Polar H10 heart rate sensor chest strap on a male subject. The image illustrates proper anatomical positioning for clinical and exercise physiology monitoring. The six precordial leads (V1-V6) are visible across the chest: V1 (4th intercostal space, right sternal border), V2 (4th intercostal space, left sternal border), V3 (midway between V2 and V4), V4 (5th intercostal space, mid-clavicular line), V5 (anterior axillary line), and V6 (mid-axillary line). The leads utilize standard color-coding (Red, Yellow, Green, Brown, Black, Violet). Limb leads are positioned at the shoulders (RA/LA) and the lower ribcage/abdominal area (RL/LL) to facilitate movement during testing. The Polar H10 chest strap is situated inferior to the pectoral muscles, intersecting the mid-precordial electrode line. This visual serves as an educational reference for electrode application in comparative heart rate variability (HRV) studies, highlighting the spatial relationship between traditional medical grade ECG sensors and wearable consumer fitness technology.

This composite educational graphic illustrates the configuration and hardware for electrocardiogram (ECG) recording. Panel A is an anatomical diagram showing the skeletal thorax with green markers indicating standard electrode placement sites, including the precordial and limb leads. Panel B presents a schematic of a human subject in the supine position, detailing the connection of exploring electrodes (labeled R, L, F, N, and V1–V6) to an EPTracer sensor system. This panel demonstrates the standardized 12-lead ECG nomenclature and the spatial distribution of chest and limb leads used to calculate potential differences against the Wilson central terminal. Panel C is a clinical photograph of the EPTracer sensor front panel, a specialized electrophysiological measurement device. The panel displays various interfaces including stimulator outputs (OUT1, OUT2), specialized ports for surface ECG and intracardiac signal acquisition, and auxiliary inputs. Control knobs for backup pacing and sensing parameters are also visible, highlighting the device's capability for both diagnostic recording and therapeutic cardiac pacing in clinical or experimental electrophysiology environments.

A clinical photograph illustrating the standardized placement of a 12-lead electrocardiogram (ECG) on a neonate. The image shows several electrodes secured to the newborn's skin using clear adhesive gel tabs (Philips brand). The electrode distribution follows neonatology guidelines to minimize motion artifacts: the four limb leads are positioned on the right and left shoulders and the right and left iliac crests, rather than the distal extremities. The precordial leads (V1-V6) are arranged across the anterior chest wall. Each electrode consists of a transparent plastic clip housing, a tapered brown connector with color-coded bands (including red, yellow, green, blue, and purple) for lead identification, and white cabling. The clinical context demonstrates the procedural adaptations required for neonatal cardiac monitoring, such as using torso placement for limb leads to improve signal-to-noise ratio in active infants.

This composite educational graphic illustrates the procedural setup and resulting data for a standard 12-lead electrocardiogram (ECG/EKG). Panels (a) and (b) are clinical photographs demonstrating correct electrode placement on a male torso. The limb leads are positioned as RA (right arm/shoulder) and LA (left arm/shoulder) on the upper chest, with RL (right leg) and LL (left leg) on the lower abdomen. The precordial leads (V1-V6) follow the standard anatomical arc across the chest: V1 and V2 at the fourth intercostal space (right and left of the sternum), V4 at the fifth intercostal space (mid-clavicular line), and V3, V5, and V6 completing the transverse sequence toward the left axilla. Panel (a) includes an inset showing the experimental use of conductive carbon nanotube yarns (SWNT-CYs) connected via alligator clips to the electrodes. Panel (c) displays the resulting 12-lead ECG waveforms on a standard grid, labeled I, II, III, aVR, aVL, aVF, and V1-V6. Each lead shows distinct P-waves, QRS complexes, and T-waves, representing different electrical vectors of cardiac depolarization and repolarization.